Roche’s phase III IMpower150 study meets co-primary endpoint of progression-free survival
Roche has announced that the phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of Tecentriq...
Chugai Pharma’s phase III HAVEN 3 study evaluating emicizumab meets primary endpoint
Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study evaluating emicizumab (ACE910) subcutaneous...
Adocia announces positive results from phase 1 study of BioChaperone Glucagon
Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of a phase 1 study...
SQI Signs Agreement With A World-Leading Pharmaceutical Company
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it...
Promentis Pharmaceuticals Commences Phase 1 Study For SXC-2023 Targeting Neuropsychiatric Disorders
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending...
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda in Europe
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced that the companies have...
Sobi begins phase 3 study evaluating safety and efficacy of anakinra to treat Still’s disease
Swedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs, to evaluate efficacy and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...